Current Topics in Medicinal Chemistry
Title:Meet Our Editorial Board Member
Volume: 20 Issue: 26
Author(s): Amit K. Gupta
Affiliation:
Export Options
About this article
Cite this article as:
Gupta K. Amit , Meet Our Editorial Board Member, Current Topics in Medicinal Chemistry 2020; 20 (26) . https://dx.doi.org/10.2174/156802662026201013110644
DOI https://dx.doi.org/10.2174/156802662026201013110644 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Artificial intelligence for Natural Products Discovery and Development
Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Gut Microbiota Might Act as a Potential Therapeutic Pathway in COVID-19
Current Pharmaceutical Biotechnology Solvent-Free Synthesis and Insecticidal Activities of C6-Esterified Coumarins
Letters in Drug Design & Discovery Drug Discovery by Drug Repurposing: Combating COVID-19 in the 21st Century
Mini-Reviews in Medicinal Chemistry Rapid Nucleic Acid Reaction Circuits for Point-of-care Diagnosis of Diseases
Current Topics in Medicinal Chemistry Angiotensin Peptides as AT2 Receptor Agonists
Current Protein & Peptide Science Impact of Entrepreneurial Support on Scientific Publications and Patent Applications
Recent Patents on Engineering Advanced Micro-Nano-Bio Systems for Future Targeted Therapies
Current Nanoscience Dexamethasone Reduces Cell Adhesion and Migration of T47D Breast Cancer Cell Line
Anti-Cancer Agents in Medicinal Chemistry Molecular Modeling of Benzimidazole Derivatives: A Promising Series of GluN2B Selective NMDA Receptor Antagonists
Current Drug Therapy Prediction of Enzyme’s Family Based on Protein-Protein Interaction Network
Current Bioinformatics A Walk in Nature: Sesquiterpene Lactones as Multi-Target Agents Involved in Inflammatory Pathways
Current Medicinal Chemistry Peptide-Based Subunit Nanovaccines
Current Drug Delivery Design, Synthesis and Biological Evaluation of Salicylamide Analogues as Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Letters in Drug Design & Discovery Should SARS CoV-2 Infection be Considered an Independent Risk Factor for <i>Pneumocystis jirovecii</i> Pneumonia? Emerging Data after Two Years of Pandemic from a Single Center Experience
Reviews on Recent Clinical Trials Flavonoids as Natural Inhibitors of Jack Bean Urease Enzyme
Letters in Drug Design & Discovery Non-Fluorinated Quinolones (NFQs): New Antibacterials with Unique Properties Against Quinolone-Resistant Gram-positive Pathogens
Current Drug Targets - Infectious Disorders Airborne Particles in Pulmonary Diseases
Current Respiratory Medicine Reviews Editorial [ Infectious Diseases: What is in our future? ]
Infectious Disorders - Drug Targets Ionotropic Glutamate Receptors & CNS Disorders
CNS & Neurological Disorders - Drug Targets Oxazolidinone-containing Hybrids with Antibacterial Activity against Methicillin-resistant <i>Staphylococcus aureus</i> (MRSA): A Mini-review
Current Topics in Medicinal Chemistry